CAG
IDXX icon

Csenge Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Csenge Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Sell
430
-1,400
-77% -$785K 0.01% 694
2026
Q1 		$1.03M Sell
1,830
-407
-18% -$261K 0.05% 289
2025
Q4 		$1.51M Buy
2,237
+1,778
+387% +$1.21M 0.07% 229
2025
Q3 		$293K Sell
459
-311
-40% -$189K 0.01% 552
2025
Q2 		$395K Sell
770
-4
-0.5% -$1.91K 0.02% 478
2025
Q1 		$318K Sell
774
-171
-18% -$74.3K 0.02% 514
2024
Q4 		$391K Sell
945
-71
-7% -$31.1K 0.02% 493
2024
Q3 		$484K Sell
1,016
-4
-0.4% -$1.94K 0.03% 431
2024
Q2 		$497K Buy
1,020
+77
+8% +$38.7K 0.03% 403
2024
Q1 		$509K Buy
943
+166
+21% +$90.7K 0.03% 429
2023
Q4 		$431K Buy
777
+225
+41% +$106K 0.03% 438
2023
Q3 		$241K Buy
552
+40
+8% +$19.9K 0.02% 539
2023
Q2 		$257K Buy
+512
New +$245K 0.02% 537
2022
Q1 		– Sell
-978
Closed -$625K – 655
2021
Q4 		$625K Sell
978
-59
-6% -$37K 0.06% 290
2021
Q3 		$647K Buy
1,037
+59
+6% +$39.6K 0.05% 310
2021
Q2 		$625K Sell
978
-38
-4% -$21K 0.06% 291
2021
Q1 		$511K Buy
1,016
+328
+48% +$164K 0.05% 269
2020
Q4 		$344K Buy
+688
New +$308K 0.04% 295
2018
Q4 		– Sell
-2
Closed – – 771
2018
Q3 		$0 Buy
+2
New +$485 ﹤0.01% 1289

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Csenge Advisory Group's IDXX Position: Q2 2026 in Review

Csenge Advisory Group reduced its Idexx Laboratories (IDXX) stake by 77% in Q2 2026, selling an estimated $785K and leaving 430 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #694.

Csenge Advisory Group first reported a position in IDXX in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.51M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Csenge Advisory Group held 430 shares of Idexx Laboratories worth $227K as of Q2 2026.
  • Csenge Advisory Group sold 1,400 Idexx Laboratories shares in Q2 2026, an estimated $785K.
  • Idexx Laboratories made up 0.01% of Csenge Advisory Group's portfolio in Q2 2026, its #694 holding.
  • Csenge Advisory Group first reported a position in Idexx Laboratories in Q3 2018 and has held it in 19 quarters since.
  • Csenge Advisory Group's Idexx Laboratories position peaked at $1.51M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.